Search Results - "Krabbe, Laura"

Partial nephrectomy versus radical nephrectomy for clinical localised renal masses by Kunath, Frank, Schmidt, Stefanie, Krabbe, Laura-Maria, Miernik, Arkadiusz, Dahm, Philipp, Cleves, Anne, Walther, Mario, Kroeger, Nils

“…Partial nephrectomy and radical nephrectomy are the relevant surgical therapy options for localised renal cell carcinoma. However, debate regarding the effects…”
Get more information

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer by Schmidt, Stefanie, Kunath, Frank, Coles, Bernadette, Draeger, Desiree Louise, Krabbe, Laura-Maria, Dersch, Rick, Kilian, Samuel, Jensen, Katrin, Dahm, Philipp, Meerpohl, Joerg J

“…People with urothelial carcinoma of the bladder are at risk for recurrence and progression following transurethral resection of a bladder tumour (TURBT)…”
Get more information

Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone by Schrader, Andres Jan, Boegemann, Martin, Ohlmann, Carsten-H, Schnoeller, Thomas J, Krabbe, Laura-Maria, Hajili, Turkan, Jentzmik, Florian, Stoeckle, Michael, Schrader, Mark, Herrmann, Edwin, Cronauer, Marcus V

“…Abstract Background Abiraterone, an androgen synthesis inhibitor, has been successfully used in the treatment of castration-resistant prostate cancer (CRPC)…”
Get full text

Molecular markers in bladder cancer by Soria, Francesco, Krabbe, Laura-Maria, Todenhöfer, Tilman, Dobruch, Jakub, Mitra, Anirban P., Inman, Brant A., Gust, Kilian M., Lotan, Yair, Shariat, Shahrokh F.

“…Purpose Use of molecular markers in urine, tissue or blood offers potential opportunities to improve understanding of bladder cancer biology which may help…”
Get full text

Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma by Margolin, Ezra J., Matulay, Justin T., Li, Gen, Meng, Xiaosong, Chao, Brian, Vijay, Varun, Silver, Hayley, Clinton, Timothy N., Krabbe, Laura-Maria, Woldu, Solomon L., Singla, Nirmish, Bagrodia, Aditya, Margulis, Vitaly, Huang, William C., Bjurlin, Marc A., Shah, Ojas, Anderson, Christopher B.

“…We evaluated the discordance between ureteroscopic biopsy and surgical pathology findings for grading and staging upper tract urothelial carcinoma. We also…”
Get full text

Risk factors for recurrence after surgery in non‐metastatic RCC with thrombus: a contemporary multicentre analysis by Abel, E. Jason, Margulis, Vitaly, Bauman, Tyler M., Karam, Jose A., Christensen, William P., Krabbe, Laura‐Maria, Haddad, Ahmed, Golla, Vishnukamal, Wood, Christopher G.

“…Objective To determine the predictors of post‐surgical recurrence for patients with non‐metastatic renal cell carcinoma (RCC) and venous thrombus. Methods…”
Get full text

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease by Wagener, Nina, Edelmann, Dominic, Benner, Axel, Zigeuner, Richard, Borgmann, Hendrik, Wolff, Ingmar, Krabbe, Laura M, Musquera, Mireia, Dell'Oglio, Paolo, Capitanio, Umberto, Klatte, Tobias, Cindolo, Luca, May, Matthias, Brookman-May, Sabine D

“…Renal cell carcinoma (RCC) comprises a heterogenous group of tumors. Traditionally, papillary RCC (pRCC) is associated with a favorable outcome compared to…”
Get full text

Prospects and progress of immunotherapy for bladder cancer by Boegemann, Martin, Aydin, Ahmet Murat, Bagrodia, Aditya, Krabbe, Laura-Maria

“…With recent advances in immunooncology and the introduction of checkpoint inhibitors into clinical practice for many cancers, the treatment landscape of…”
Get more information

Impact of hospital case volume on testicular cancer outcomes and practice patterns by Woldu, Solomon L., Matulay, Justin T., Clinton, Timothy N., Singla, Nirmish, Krabbe, Laura-Maria, Hutchinson, Ryan C., Sagalowsky, Arthur, Lotan, Yair, Margulis, Vitaly, Bagrodia, Aditya

“…Given the rarity of testicular germ cell tumors (TGCTs) and the complex aspects of management, we evaluate the effect of hospital TGCT case volume on overall…”
Get full text

Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients by Schlack, Katrin, Seitzer, Konstantin, Wüstmann, Neele, Humberg, Verena, Grundmann, Norbert, Steinestel, Julie, Tiedje, Dorothee, Rahbar, Kambiz, Krabbe, Laura-Maria, Bögemann, Martin, Schrader, Andres J., Bernemann, Christof

“…Biomarker in metastatic castration resistant prostate cancer (mCRPC) treatment are rare. We aimed to compare the clinical value of circulating tumor cells…”
Get full text

Prognostic value of tissue‐based biomarker signature in clear cell renal cell carcinoma by Haddad, Ahmed Q., Luo, Jun‐Hang, Krabbe, Laura‐Maria, Darwish, Oussama, Gayed, Bishoy, Youssef, Ramy, Kapur, Payal, Rakheja, Dinesh, Lotan, Yair, Sagalowsky, Arthur, Margulis, Vitaly

“…Objective To improve risk stratification for recurrence prognostication in patients with localised clear cell renal cell carcinoma (ccRCC). Patients and…”
Get full text

Should patients newly diagnosed with bladder cancer be screened for lung cancer? by Krabbe, Laura-Maria, Lotan, Yair

Get full text

Perioperative Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Cava Thrombus Extending Above the Hepatic Veins: A Contemporary Multicenter Experience by Abel, E. Jason, Thompson, R. Houston, Margulis, Vitaly, Heckman, Jennifer E, Merril, Megan M, Darwish, Oussama M, Krabbe, Laura-Maria, Boorjian, Stephen A, Leibovich, Bradley C, Wood, Christopher G

“…Abstract Background Surgery for renal cell carcinoma (RCC) patients with inferior vena cava (IVC) thrombus above the hepatic veins is technically complex and…”
Get full text

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer by Mikah, Phillip, Krabbe, Laura-Maria, Eminaga, Okyaz, Herrmann, Edwin, Papavassilis, Philipp, Hinkelammert, Reemt, Semjonow, Axel, Schrader, Andres-Jan, Boegemann, Martin

“…Significant progress in treatment of metastatic castration resistant prostate cancer (mCRPC) has been made. Biomarkers to tailor therapy are scarce. To…”
Get full text

Artificial Intelligence Reveals Distinct Prognostic Subgroups of Muscle-Invasive Bladder Cancer on Histology Images by Eminaga, Okyaz, Leyh-Bannurah, Sami-Ramzi, Shariat, Shahrokh F, Krabbe, Laura-Maria, Lau, Hubert, Xing, Lei, Abbas, Mahmoud

“…Muscle-invasive bladder cancer (MIBC) is a highly heterogeneous and costly disease with significant morbidity and mortality. Understanding tumor histopathology…”
Get full text

Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy by Zargar, Homayoun, Shah, Jay B., van Rhijn, Bas W., Daneshmand, Siamak, Bivalacqua, Trinity J., Spiess, Philippe E., Black, Peter C., Kassouf, Wassim, Fransen van de Putte, Elisabeth E., Horenblas, Simon, Potvin, Kylea R., Winquist, Eric, Seah, Jo-An, Sridhar, Srikala S., Jacobsen, Niels-Erik, Zargar-Shoshtari, Kamran, Holzbeierlein, Jeff M., Griffin, Joshua, Dinney, Colin, Krabbe, Laura-Maria, Lotan, Yair, Kovac, Evan, Ercole, Cesar E., Stephenson, Andrew J., Grivas, Petros, Cookson, Michael S., Baras, Alex, Montgomery, Jeffrey S., Morgan, Todd M., Vasdev, Nikhil, Thorpe, Andrew C., Campain, Nicholas J., McGrath, John S., Yu, Evan Y., Wright, Jonathan L., Xylinas, Evanguelos, Dall'Era, Marc A., Barocas, Daniel A., Fairey, Adrian S., Shariat, Shahrokh F., Aning, Jonathan

“…Level I evidence supports the usefulness of neoadjuvant cisplatin based chemotherapy for muscle invasive bladder cancer. Since dose dense MVAC (methotrexate,…”
Get full text

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy by Raman, Jay D., Lin, Yu‐Kuan, Shariat, Shahrokh F., Krabbe, Laura‐Maria, Margulis, Vitaly, Arnouk, Alex, Lallas, Costas D., Trabulsi, Edouard J., Drouin, Sarah J., Rouprêt, Morgan, Bozzini, Gregory, Colin, Pierre, Peyronnet, Benoit, Bensalah, Karim, Bailey, Kari, Canes, David, Klatte, Tobias

“…Objectives To construct a nomogram based on preoperative variables to better predict the likelihood of complications occurring within 30 days of radical…”
Get full text

ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis by Schlack, Katrin, Krabbe, Laura-Maria, Rahbar, Kambiz, Isenberg, Karoline, Semjonow, Axel, Schrader, Andres Jan, Boegemann, Martin

“…In bone metastatic castration-resistant prostate cancer (bmCRPC) treated with Enzalutamide commonly used prostate-specific antigen (PSA) can be misleading…”
Get full text

Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study by Foerster, Beat, Abufaraj, Mohammad, Matin, Surena F., Azizi, Mounsif, Gupta, Mohit, Li, Wei-Ming, Seisen, Thomas, Clinton, Timothy, Xylinas, Evanguelos, Mir, M. Carmen, Schweitzer, Donald, Mari, Andrea, Kimura, Shoji, Bandini, Marco, Mathieu, Romain, Ku, Ja H., Marcq, Gautier, Guruli, Georgi, Grabbert, Markus, Czech, Anna K., Muilwijk, Tim, Pycha, Armin, D’Andrea, David, Petros, Firas G., Spiess, Philippe E., Bivalacqua, Trinity, Wu, Wen-Jeng, Rouprêt, Morgan, Krabbe, Laura-Maria, Hendricksen, Kees, Egawa, Shin, Briganti, Alberto, Moschini, Marco, Graffeille, Vivien, Kassouf, Wassim, Autorino, Riccardo, Heidenreich, Axel, Chlosta, Piotr, Joniau, Steven, Soria, Francesco, Pierorazio, Phillip M., Shariat, Shahrokh F.

“…Several groups have proposed features to identify low-risk patients who may benefit from endoscopic kidney-sparing surgery in upper tract urothelial carcinoma…”
Get full text

The safety and efficacy of gemcitabine for the treatment of bladder cancer by Schlack, Katrin, Boegemann, Martin, Steinestel, Julie, Schrader, Andres Jan, Krabbe, Laura-Maria

“…Bladder cancer is a common type of cancer with an estimated incidence of more than 70,000 patients and had a mortality of 16,000 patients in the US in 2015. In…”
Get full text